Age is the primary risk factor for a host of chronic diseases, including diabetes, cancer and tissue degeneration. BIOAGE uses a unique computational platform that explores a universe of public and proprietary data to identify and target the molecular factors that influence longevity.
BIOAGE has a diverse team of computational biologists and medical scientists with expertise in aging and translational research. We share the vision that a synergy of machine learning approaches, high throughput human omics data, and new experimental approaches will make it possible to discover therapies that address unmet medical needs in an aging population.
Age-related diseases are becoming increasingly prevalent. Recent advances in the development of high throughput omics technologies and computational methods, coupled with new scientific discoveries about the fundamental biology of aging, offer an unprecedented opportunity for discovering and targeting the molecular pathways that drive aging.